We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+11.39%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$634M
AUM Growth
+$113M
(+22%)
Cap. Flow
+$79.5M
Cap. Flow
% of AUM
12.54%
Top 10 Holdings %
Top 10 Hldgs %
42.47%
Holding
197
New
65
Increased
36
Reduced
30
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$17.1M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$14.1M |
| 3 |
Elevance Health
ELV
|
+$12.8M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$12.6M |
| 5 |
STAAR Surgical
STAA
|
+$10.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$25.1M |
| 2 |
Amazon
AMZN
|
+$13.4M |
| 3 |
Synopsys
SNPS
|
+$8.98M |
| 4 |
Knight Transportation
KNX
|
+$8.3M |
| 5 |
AMRS
Amyris Inc.
AMRS
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.88% |
| 2 | Healthcare | 13.86% |
| 3 | Industrials | 10.8% |
| 4 | Consumer Discretionary | 4.6% |
| 5 | Consumer Staples | 4.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Medtronic
MDT
$112B
| $779K | 0.12% |
8,000
| – | – |
|
77
Resideo Technologies
REZI
$5.39B
| $764K | 0.12% |
35,000
| – | – |
|
78
Becton Dickinson
BDX
$46.5B
| $756K | 0.12% |
+3,075
| New | +$714K |
|
|
VTNR
79
DELISTED
Vertex Energy, Inc
VTNR
| $756K | 0.12% |
504,306
+4,000
| +0.8% | +$5.99K |
|
80
Electronic Arts
EA
$52.3B
| $709K | 0.11% |
7,000
-2,000
| -22% | -$191K |
|
81
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $658K | 0.1% |
7,500
-57,500
| -88% | -$4.9M |
|
82
SolarEdge
SEDG
$2.4B
| $655K | 0.1% |
+10,500
| New | +$530K |
|
|
ALXN
83
DELISTED
Alexion Pharmaceuticals
ALXN
| $653K | 0.1% |
5,000
+1,500
| +43% | +$193K |
|
|
COUP
84
DELISTED
Coupa Software Incorporated
COUP
| $633K | 0.1% |
5,000
-42,500
| -89% | -$4.56M |
|
85
PUT
Zscaler
ZS
$24.7B
| $613K | 0.1% |
+8,000
| New | +$570K |
|
86
Merck
MRK
$324B
| $587K | 0.09% |
+7,336
| New | +$562K |
|
|
GTLS
87
DELISTED
Chart Industries
GTLS
| $576K | 0.09% |
+7,500
| New | +$616K |
|
88
Harrow
HROW
$1.45B
| $566K | 0.09% |
65,000
-10,000
| -13% | -$55.2K |
|
89
Coherus Oncology
CHRS
$222M
| $553K | 0.09% |
25,000
-25,000
| -50% | -$434K |
|
90
Bloom Energy
BE
$48B
| $549K | 0.09% |
+45,000
| New | +$552K |
|
91
iShares Biotechnology ETF
IBB
$9.52B
| $546K | 0.09% |
5,000
-3,000
| -38% | -$319K |
|
|
CSOD
92
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $521K | 0.08% |
+9,000
| New | +$487K |
|
|
DQ
93
Daqo New Energy
DQ
$823M
| $508K | 0.08% |
+60,000
| New | +$458K |
|
94
Insulet
PODD
$11.7B
| $478K | 0.08% |
+4,000
| New | +$410K |
|
|
QTNT
95
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $468K | 0.07% |
1,250
-500
| -29% | -$179K |
|
96
FIVE9
FIVN
$2.13B
| $462K | 0.07% |
+9,000
| New | +$457K |
|
97
PUT
Roku
ROKU
$21.4B
| $453K | 0.07% |
+5,000
| New | +$401K |
|
98
Cerus
CERS
$589M
| $449K | 0.07% |
80,000
| – | – |
|
99
Elanco Animal Health
ELAN
$12.9B
| $442K | 0.07% |
13,068
| – | – |
|
|
PFPT
100
DELISTED
Proofpoint, Inc.
PFPT
| $421K | 0.07% |
3,500
-1,500
| -30% | -$177K |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
PHS
Ardsley Advisory Partners's Q2 2019 Portfolio in Review
As of Q2 2019, Ardsley Advisory Partners held 197 positions worth $634M, up 22% from $521M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Ardsley Advisory Partners deployed $79.5M of net new capital in Q2 2019, opening 65 new positions and adding to 36 existing holdings. Its largest new stake was Organigram Holdings: 250,000 shares worth $6.44M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Celgene Corp, an estimated $25.1M trimmed.
- Ardsley Advisory Partners's largest Q2 2019 buy was Organigram Holdings: 250,000 shares worth $6.44M.
- Ardsley Advisory Partners added most to Walt Disney in Q2 2019, an estimated $17.1M increase.
- Ardsley Advisory Partners's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $25.1M.
- Ardsley Advisory Partners fully exited Amazon in Q2 2019, selling an estimated $13.4M.
- Ardsley Advisory Partners's ten largest holdings make up 42% of its $634M portfolio in Q2 2019.
- Ardsley Advisory Partners opened 65 new positions and closed 49 in Q2 2019.
- Ardsley Advisory Partners's portfolio value rose 22% quarter-over-quarter to $634M.
Based on Ardsley Advisory Partners's 13F filing for Q2 2019, filed 13 Aug 2019.